R. Port

477 total citations
9 papers, 343 citations indexed

About

R. Port is a scholar working on Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Port has authored 9 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Port's work include Carcinogens and Genotoxicity Assessment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Electron Spin Resonance Studies (2 papers). R. Port is often cited by papers focused on Carcinogens and Genotoxicity Assessment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Electron Spin Resonance Studies (2 papers). R. Port collaborates with scholars based in Germany, Netherlands and Italy. R. Port's co-authors include B. Begliomini, L. Lindgren, I. Quintus Molenaar, J Hermans, Theo H.N. Groenland, Gualtiero Palareti, Anna Januszkiewicz, Onno T. Terpstra, J. Wahrendorf and D Schmähl and has published in prestigious journals such as The Lancet, International Journal of Cancer and European Journal of Clinical Pharmacology.

In The Last Decade

R. Port

9 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Port Germany 6 132 121 68 59 53 9 343
Shirley L. Rivers United States 11 134 1.0× 19 0.2× 127 1.9× 55 0.9× 52 1.0× 19 424
C Cordova Italy 12 77 0.6× 147 1.2× 18 0.3× 28 0.5× 146 2.8× 28 401
Paul Mitruț Romania 11 112 0.8× 165 1.4× 9 0.1× 35 0.6× 170 3.2× 49 536
Cristina Pollard United Kingdom 13 162 1.2× 38 0.3× 39 0.6× 17 0.3× 43 0.8× 17 459
Jay Patel United States 8 134 1.0× 12 0.1× 23 0.3× 19 0.3× 57 1.1× 21 462
Kip D. Lyche United States 9 133 1.0× 203 1.7× 13 0.2× 9 0.2× 206 3.9× 13 428
L. Corbel France 9 128 1.0× 76 0.6× 14 0.2× 8 0.1× 29 0.5× 28 368
Carmen Serena Ricci Italy 5 62 0.5× 100 0.8× 9 0.1× 19 0.3× 120 2.3× 9 292
Murugesan Manoharan United States 12 194 1.5× 8 0.1× 73 1.1× 23 0.4× 5 0.1× 25 553
Mohammad Reza Deyhim Iran 8 32 0.2× 44 0.4× 88 1.3× 9 0.2× 110 2.1× 27 317

Countries citing papers authored by R. Port

Since Specialization
Citations

This map shows the geographic impact of R. Port's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Port with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Port more than expected).

Fields of papers citing papers by R. Port

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Port. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Port. The network helps show where R. Port may publish in the future.

Co-authorship network of co-authors of R. Port

This figure shows the co-authorship network connecting the top 25 collaborators of R. Port. A scholar is included among the top collaborators of R. Port based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Port. R. Port is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Grubert, M., et al.. (2002). The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin – a population based pharmacokinetic study of CESAR-APOH. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 575–577. 1 indexed citations
2.
Port, R., I. Quintus Molenaar, B. Begliomini, et al.. (2000). Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. The Lancet. 355(9212). 1303–1309. 213 indexed citations
3.
Kissel, J. T., Gunnar Brix, Matthias E. Bellemann, et al.. (1997). Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.. PubMed. 57(16). 3415–23. 56 indexed citations
4.
Bouillon, Thomas, et al.. (1996). Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age. European Journal of Clinical Pharmacology. 51(2). 153–160. 11 indexed citations
5.
Brix, Gunnar, Willi Semmler, R. Port, et al.. (1991). Pharmakokinetische Analyse des MRT-Signalverlaufs vor, während und nach i.v. Gd-DTPA-Infusion. Zeitschrift für Medizinische Physik. 1(3). 119–121. 1 indexed citations
6.
Herrmann, Richard, et al.. (1988). Folinic acid effect on 5-fluorouracil kinetics in vivo. Journal of Cancer Research and Clinical Oncology. 114(1). 87–90. 2 indexed citations
7.
Schmähl, D, R. Port, & J. Wahrendorf. (1977). A dose‐response study on urethane carcinogenesis in rats and mice. International Journal of Cancer. 19(1). 77–80. 42 indexed citations
8.
Ivanković, S., R. Port, & R. Preußmann. (1976). Unterschiedliche carcinogene Wirkungen von 1-Phenyl- und 1-(Pyridyl-3)-3,3-di�thyl-triazen an BD-Ratten nach Gabe einer Einzeldosis am 1., 10. oder 30. Lebenstag. Journal of Cancer Research and Clinical Oncology. 86(3). 307–313. 6 indexed citations
9.
Port, R., D. Schmähl, & J. Wahrendorf. (1976). Some Examples of Dose-Response Studies in Chemical Carcinogenesis. Oncology. 33(2). 66–71. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026